key: cord-0928893-el2gicn6 authors: Liu, Weiping; Long, Xia; Wan, Kexing; Yin, Minggang; Yin, Yi; Zhang, Bo; Li, Lin; Song, Yaohui title: The endogenous factors affecting the detection of serum SARS‐CoV‐2 IgG/IgM antibodies by ELISA date: 2022-01-07 journal: J Med Virol DOI: 10.1002/jmv.27557 sha: 6d9c615a4b50bb1fee024616ad9f2a0f76a614fc doc_id: 928893 cord_uid: el2gicn6 To investigate endogenous interference factors of the detection results of novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) IgM/IgG. Enzyme‐linked immunosorbent assay (ELISA) was used to detect SARS‐CoV‐2 IgM/IgG in sera of 200 patients without COVID‐19 infection, including rheumatoid factor (RF) positive group, antinuclear antibody (ANA) positive group, pregnant women group, and normal senior group, with 50 in each group and 100 normal controls. The level of SARS‐CoV‐2 IgG in pregnant women was significantly higher than that in the normal control group (p = 0.000), but there was no significant difference between other groups. The levels of SARS‐CoV‐2 IgM in the pregnant women group, normal senior group, ANA positive group, and RF positive group were significantly higher than that in the normal control group (p < 0.05), with significant higher false‐positive rates in these groups (p = 0.036, p = 0.004, p = 0.000, vs. normal control group). Serum RF caused SARS‐CoV‐2 IgM false‐positive in a concentration‐dependent manner, especially when its concentration was higher than 110.25 IU/L, and the urea dissociation test can turn the false positive to negative. ANA, normal seniors, pregnant women, and RF can lead to false‐positive reactivity of SARS‐CoV‐2 IgM and/or IgG detected using ELISA. These factors should be considered when SARS‐CoV‐2 IgM or IgG detection is positive, false positive samples caused by RF positive can be used for urea dissociation test. antibodies by enzyme-linked immunosorbent assay (ELISA) is a quick and simple screening method. 7 Nowadays, the challenge of antibody analysis is to ensure its sensitivity and specificity. Although many newly developed tests are available, in many cases, ELISA serological tests could produce false-positive results due to a variety of factors. 8 It was shown in multiple works that rheumatoid factor (RF) can interfere with the detection of antigens or antibodies in serum by ELISA, resulting in a false-positive result. 9 Another study reported that there are certain false-positive rates when pregnant women used ELISA to detect serum cytomegalovirus (CMV) IgG levels. 10 Some patients with autoimmune diseases can also cause falsepositive detection of serum SARS-CoV antibodies by ELISA. 11 However, few systematic reports on the factors affecting the de- The study population consisted of 300 patients without infection who were hospitalized in the First People's Hospital of Zigong City from February 1 to October 30, 2020. 50 normal seniors (25 males and 25 females) and 50 normal pregnant women were excluded from endocrine system, cardiovascular and cerebrovascular diseases, tumors, infections, autoimmune diseases, liver diseases, kidney diseases, and other system diseases; 50 antinuclear antibody (ANA) positive patients and 50 RF positive patients, all of them excluded endocrine system, cardiovascular and cerebrovascular diseases, tumors, infections, liver diseases, kidney diseases, and other system diseases. All patients (participants or individuals) were admitted to the hospital and tested for nucleic acid and all were negative, which ruled out COVID-19 infection. Among the physical examination population, 15 normal people, aged 18-30, were selected to exclude systemic diseases such as endocrine system, cardiovascular and cerebrovascular diseases, tumors, infections, autoimmune diseases, liver diseases, and kidney diseases. The sera of 15 selected individuals were collected and divided into three groups on average. The sera of each group were mixed to form three mixed samples, which were shaken and mixed evenly for substitution. SARS-CoV-2 nucleic acid was detected using real-time PCR (RT-PCR) (kit provided by Sichuan Maccura Biotechnology Co.; detection instrument provided by Shanghai Hongshi Biotechnology Co.). ELISA was used for SARS-CoV-2 IgM detection (kit provided by Zhuhai Lizhu Reagent Co.: lot no. 2020021408). The optical density in ELISA plates was measured using a microplate reader (Thermo Fisher Scientific). Epidemiological, clinical, laboratory, management, and outcome data were collected through a review of medical records. Real-time RT-PCR confirmed that all patients were negative for SARS-CoV-2. Serum (5 μl) was added to a 500 μl sample diluent and mixed. Then Analysis of normality and homogeneity of variance is carried out on the measurement data. If the data conforms to the normal distribution, it is displayed by ±s, and t-test was used for difference analysis; if the data does not conform to the normal distribution, it is expressed as the median (quartile)M(P25, P75), Mann-Whitney U-test was used for variance analysis. Qualitative data were analyzed by the X 2 test. SPSS 21.0 statistical software was used for statistical analysis of the data, and Statistical significance was defined as p < 0.05. Other data were displayed as tables and line charts. Three mixed sera were prepared and measured for SARS-CoV-2 IgG and IgM, respectively. Each mixed serum was measured 20 times in the same batch to obtain the intra-batch precision (Table 1) , and for 20 consecutive days to obtain the inter-batch precision ( Table 2 ). The coefficient variations (CVs) of intra-batch and inter-batch precision for all samples were ≤15%. It is concluded that this method has a certain accuracy in detecting serum SARS-CoV-2 IgG and IgM. The test results of negative controls were less than the cutoff value in the reagent specification, and the levels of all positive controls were far greater than the specified cutoff value. We also detected eight SARS-CoV-2 positive samples (confirmed by RT-PCR), which were positive for SARS-CoV-2 IgG and IgM (Table 3 ). These indicated that the test was working properly. Figure 1C ). In addition, there were false positives in the seniors' group, ANA positive group, and RF positive group, and the false-positive rates were 3/50, 5/50, and 20/50, respectively. Compared with the normal control, it was statistically significant (p = 0.036, p = 0.004, p = 0.000; Figure 1D ). Moreover, the concentration of RF leading to a high false-positive rate in SARS-COV-2 IgM detection can cause false-positive results, which need to be further studied. The authors gratefully acknowledge the intense individual effort and support from many sources to make this study possible. This study was supported by the Sichuan Medical Scientific Research Funding (Q18025). The authors declare that there are no conflict of interests. This study was reviewed and approved by the Ethics Committee of The data that support the findings of this study are available from the corresponding author upon reasonable request. https://orcid.org/0000-0001-9527-9136 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding First case of 2019 novel coronavirus in the United States Rapid versus standard testing for prenatal HIV screening in a predominantly Hispanic population Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers Dynamic monitoring of immune function indexes in COVID-19 patients Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the COVID-19 crisis Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid Dual-antigen system allows elimination of false positive results in COVID-19 serological testing Determination of rheumatoid factors by ELISA Low-level positive results in the Liaison CMV IgG II assay may misclassify pregnant woman as immune Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies A critical review on SARS-CoV-2 infectivity in water and wastewater. What do we know? Predictors of negative first SARS-CoV-2 RT-PCR despite final diagnosis of COVID-19 and association with outcome Addendum: a pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human respiratory disease in China Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays Screening and exclusion of Zika virus infection in travellers by an NS1-based ELISA and qRT-PCR